These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7918951)

  • 1. [Thrombopenia secondary to hydroxychloroquine].
    Caminal Montero L; González Marroquín A; Ferro Mosquera J; Susano R
    An Med Interna; 1994 Jun; 11(6):310. PubMed ID: 7918951
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sjögren's syndrome.
    Okan G; Karaaslan M; Büyükbabani N
    Clin Exp Dermatol; 2010 Jun; 35(4):442-3. PubMed ID: 19886967
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxycholoroquine-induced hyperpigmentation.
    Mir A; Boyd KP; Meehan SA; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
    Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
    Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine.
    Lakhanpal S; Duffy J; Griffing WL; Conn DL; Luthra HS
    J Rheumatol; 1985 Oct; 12(5):1028-9. PubMed ID: 4087260
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine-associated, photo-induced toxic epidermal necrolysis.
    Callaly EL; FitzGerald O; Rogers S
    Clin Exp Dermatol; 2008 Aug; 33(5):572-4. PubMed ID: 18477009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine.
    Sibilia J; Cribier B; Javier RM; Pflumio F; Kuntz JL
    Rev Rhum Engl Ed; 1995 Dec; 62(11):795-7. PubMed ID: 8869222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergence of patient-reported xerostomia and oral health in primary Sjögren's syndrome and the possible role of hydroxychloroquine.
    Alunno A; Carubbi F; Mariani FM; Cipollone J; Rossi M; Ferri C
    Rheumatology (Oxford); 2024 Feb; 63(2):e34-e36. PubMed ID: 37490452
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine-induced hyperpigmentation: a case report.
    Melikoglu MA; Melikoglu M; Gurbuz U; Budak BS; Kacar C
    J Clin Pharm Ther; 2008 Dec; 33(6):699-701. PubMed ID: 19138249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome with myocarditis. Report of a case.
    Wang YX
    Chin Med J (Engl); 1981 Jan; 94(1):45-6. PubMed ID: 6785023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary Gougerot-Sjögren syndrome. Favourable effect of a fundamental treatment with hydroxychloroquine on biological anomalies].
    Chaouat D; Aron Rosa D; Aron B
    Rev Rhum Mal Osteoartic; 1988 Oct; 55(10):797-8. PubMed ID: 3194698
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of Sjögren's syndrome associated with macroglobulinemia which responded excellently to chlorambucil].
    Ota H; Tanaka M; Ikeda Y; Kunii A
    Rinsho Ketsueki; 1974 Dec; 15(12):1353-61. PubMed ID: 4219429
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of ethamsylate in a case of hyperglobulinemic purpura associated with Sjogren's syndrome.
    Casas HA
    J Rheumatol; 1996 Mar; 23(3):573. PubMed ID: 8833011
    [No Abstract]   [Full Text] [Related]  

  • 17. Sjogren's syndrome. When your tissues dry out.
    Mayo Clin Health Lett; 2006 Jul; 24(7):7. PubMed ID: 16865802
    [No Abstract]   [Full Text] [Related]  

  • 18. RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sjögren's syndrome.
    Pertovaara M; Korpela M
    Clin Exp Rheumatol; 2017; 35(4):718. PubMed ID: 28516885
    [No Abstract]   [Full Text] [Related]  

  • 19. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
    Ivo R; Lopes CA; Reis R
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome.
    Vivancos J; Vila M; Serra A; Loscos J; Anguita A
    Rheumatology (Oxford); 2002 Apr; 41(4):471-3. PubMed ID: 11961184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.